Medullary Sponge Kidney and Its Relationship with Primary Distal Renal Tubular Acidosis: Case Reports and a Comprehensive Genetics-First Approach

Nephron. 2024;148(8):569-577. doi: 10.1159/000538037. Epub 2024 Mar 8.

Abstract

Medullary sponge kidney (MSK) is a description of radiographic features. However, the pathogenesis of MSK remains unclear. MSK is supposed to be the cause of secondary distal renal tubular acidosis (dRTA), although there are case reports suggesting that MSK is a complication of primary dRTA. In addition to these reports, we report 3 patients with metabolic acidosis and MSK, in whom primary dRTA is confirmed by molecular genetic analyses of SLC4A1 and ATP6V1B1 genes. With a comprehensive genetics-first approach using the 100,000 Genomes Rare Diseases Project dataset, the association between MSK and primary dRTA is examined. We showed that many patients with MSK phenotypes are genetically tested with a gene panel which does not contain dRTA-associated genes, revealing opportunities for missed genetic diagnosis. Our cases highlight that the radiological description of MSK is not a straightforward disease or clinical phenotype. Therefore, when an MSK appearance is noted, a broader set of causes should be considered including genetic causes of primary dRTA as the underlying reason for medullary imaging abnormalities.

Keywords: Case reports; Distal renal tubular acidosis; Genetics; Medullary sponge kidney; Nephrocalcinosis.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acidosis, Renal Tubular* / genetics
  • Adult
  • Anion Exchange Protein 1, Erythrocyte / genetics
  • Female
  • Humans
  • Male
  • Medullary Sponge Kidney* / complications
  • Medullary Sponge Kidney* / genetics
  • Middle Aged
  • Vacuolar Proton-Translocating ATPases / genetics

Substances

  • ATP6V1B1 protein, human
  • Vacuolar Proton-Translocating ATPases
  • SLC4A1 protein, human
  • Anion Exchange Protein 1, Erythrocyte

Grants and funding

This work was supported by the Dutch Kidney Foundation (18OKG19). J.A.S. is funded by Kidney Research UK and the Northern Counties Kidney Research Fund.